AxoGen: Q1 Earnings Snapshot

AxoGen Inc. reported a first quarter loss of $19.6 million, or 38 cents per share, while adjusted earnings came in at 7 cents. Revenue reached $61.5 million, topping the $58.7 million expected by analysts surveyed by Zacks. The regenerative medicine company projected full-year revenue of $270 million. Shares are up 20% since the beginning of the year and have more than doubled over the past year. This story was generated by Automated Insights using data from Zacks Investment Research.